| Akribion–Bruker: investment, 202502 seed financing round totalling €8m incl co-investor Bruker Invest |
2025-02-04 |
| Akribion–High-Tech Gründerfonds: investment, 202502 seed financing round totalling €8m incl co-investor HTGF |
2025-02-04 |
| Akribion–Optimum Strategic Communications: public relations, 202502 service existent by Optimum |
2025-02-04 |
| Akribion–SEVERAL: investment, 202502 seed financing round €8m led by Carma Fund + RV Invest |
2025-02-04 |
| Knauer–Labomatic Instruments: liquid chromatography 202502– collab strategic combining HPLC offerings to customers incl sales + service |
2025-02-03 |
| Bureau Veritas–SGS: investment, 202501– confirmed merger discussion |
2025-01-15 |
| Owlstone–Aviva: investment, 202501 financing round Series E first closing totalling $27m incl existing + co-investor Aviva Ventures |
2025-01-15 |
| Owlstone–Gates Foundation: grant, 202404– initial $1.5m grant to develop breat-based diagnostics for developing countries from Gates Foundation |
2025-01-15 |
| Owlstone–Horizons Ventures: investment, 202501 financing round Series E first closing totalling $27m incl existing + co-investor Horizon Ventures |
2025-01-15 |
| Owlstone–SEVERAL: investment, 202501 financing round Series E first closing $27m led by Ventura Capital |
2025-01-15 |
| Owlstone–Ventura Capital: investment, 202501 financing round Series E first closing totalling $27m incl existing + lead investor Ventura Capital |
2025-01-15 |
| Mérieux–JPMorgan Chase: investor conference, 202501 supply service bioMérieux presents at JP Morgan Healthcare Conference 2025 |
2025-01-14 |
| SpinChip Diagnostics–Mérieux: investment, 202501– acquisition of remaining 80% of SpinChip for €111m in cash by bioMérieux |
2025-01-13 |
| Univ Zurich–Bruker: NMR spectrometer, 202412 supply 1.2 GHz Ascend NMR spectrometer to Swiss High-field NMR Facility at UZH |
2024-12-20 |
| Bruker–Ion Opticks: liquid chromatography, 202412– supply costum chromatography column for MS-based proteomic services to Biognosys |
2024-12-05 |
| HexagonFab–Merck (DE): investment, 202412 financing round Series A totalling £6.6m of Abselion incl lead investor M Ventures |
2024-12-04 |
| HexagonFab–SEVERAL: investment, 202412 financing round Series A £6.6m of Abselion led by M Ventures |
2024-12-04 |
| miDiagnostics–Alychlo: investment, 202412 financing round Series D totalling €30m incl existing + co-investor Alychlo |
2024-12-04 |
| miDiagnostics–Pamica: investment, 202412 financing round Series D totalling €30m incl existing + co-investor Pamica |
2024-12-04 |
| miDiagnostics–SEVERAL: investment, 202412 financing round Series D €30m led by Thermo Fisher Scientific |
2024-12-04 |
| miDiagnostics–Thermo Fisher: investment, 202412 financing round Series D totalling €30m incl lead investor Thermo Fisher Scientific |
2024-12-04 |
| miDiagnostics–VMF Invest: investment, 202412 financing round Series D totalling €30m incl existing + co-investor VMF Invest |
2024-12-04 |
| Bico–RAG: investment, 202411 acquisition €26m of Nanoscribe from Bico Group by LAB14 GmbH |
2024-11-21 |
| Mainz Biomed–Thermo Fisher: colorectal cancer screening test, 202411– collab developm + commercialisation assays for mRNA-based CRC screening tests |
2024-11-12 |
| Bureau Veritas–Mérieux: investment, 202410– acquisition €360m of global food testing of Bureau Veritas by Mérieux NutriSciences |
2024-10-07 |
| Danaher–CrestOptics: spinning disk microscopy, 202410– collab integration of Cicero spinning disk unit into Thunder Imager of Leica Microsystems |
2024-10-07 |
| Dynamic Biosensors–Bruker: investment, 202410 acquisition €na of Dynamic Biosensors GmbH + integration in Bruker Biosensors business |
2024-10-02 |
| Ion Opticks–Adelis Equity Partners: investment, 202409 strategic investment by Adelis Equity Partners |
2024-09-10 |
| Immunocore–Danaher: data management software, 202409– supply Genedata SDMS for discovery of TCR therapeutics |
2024-09-05 |
| Alphalytik Pharmaservice–Certania: investment, 202409 acquisition of Alphalytik Pharmaservice GmbH by Certania |
2024-09-04 |
| Irubis–SEVERAL: investment, 202408 financing round pre-Series A led by new investor BioProcess360 Partners |
2024-08-29 |
| mzio–Bremen (govt): grant, 202408 grant funding €150k from BAB co-funded by EU |
2024-08-21 |
| Genedata–Danaher: investment, 202408 acquisition of Genedata that will join Danaher’s Life Science segment |
2024-08-19 |
| Bruker–Novalix: drug discovery technology, 202408– strategic collab to enable new paradigms in drug discovery |
2024-08-07 |
| Novalix–Bruker: investment, 202408 strategic minority investment €na by Bruker |
2024-08-07 |
| Thermo Fisher–Biomatter Designs: enzyme design, 202408 supply existent customer Thermo Fisher |
2024-08-05 |
| OHMX.bio–Anacura: investment, 202407 acquisition of OHXM.bio by Anacura |
2024-07-04 |
| Enantios–SEVERAL: investment, 202407 seed financing round >CHF1.8m led by Privilège Ventures |
2024-07-01 |
| Leibniz-Gemeinschaft–Bruker: NRM spectrometer, 202406 supply Avance 1.2 GHz NMR system to FMP Berlin-Buch |
2024-06-30 |
| CatSci–Keensight Capital: investment, 202406 additional investment? by Keensight to support acquisition of Reach Separations by CatSci |
2024-06-25 |
| Reach Separations–CatSci: investment, 202406 acqusition of Reach Separations by CatSci Ltd with support from Keensight Capital |
2024-06-25 |
| Sartorius–Nvidia: AI-based drug discovery + manufacturing, 202405– collab expansion incl adaption of Nvidia Clara Suite + DGX platform |
2024-05-16 |
| Sartorius–Sanofi: biopharmaceutical production technology, 202405– collab + license developm of ICB platform to be excl commercialised by Sartorius ww |
2024-05-13 |
| Owlstone–Gates Foundation: investment, 202501 financing round Series E first closing totalling $27m incl $5m from new + co-investor Gates Foundation |
2024-04-25 |
| IsoSpec Analytics–Another.vc: investment, 202404 pre-seed financing round totalling $1.9m incl co-investor Another.vc |
2024-04-16 |
| IsoSpec Analytics–Founderful: investment, 202404 pre-seed financing round totalling $1.9m incl lead investor Founderful |
2024-04-16 |
| IsoSpec Analytics–SEVERAL: investment, 202404 pre-seed financing round $1.9m led by Founderful |
2024-04-16 |
| IsoSpec Analytics–Tiny.vc: investment, 202404 pre-seed financing round totalling $1.9m incl co-investor Tiny.vc |
2024-04-16 |
| IsoSpec Analytics–Venture Kick: investment, 202404 pre-seed financing round totalling $1.9m incl co-investor Venture Kick |
2024-04-16 |
| Tagomics–SEVERAL: investment, 202402 financing round £6.7m led by Calculus Capital |
2024-02-21 |
| Tagomics–SEVERAL: investment, <202402 pre-seed financing round £1.6m (incl grant from Innovate UK) |
2024-02-21 |
| Waters–Plasmion: ionisation technology, 202402– collab co-marketing/promotion of SICRIT ion source with Waters Acquity QDa + Select Series Cycli IMS |
2024-02-21 |
| Sysmex–SAFIA Technologies: mycotoxin immunoassays, 202402– distribution ww of tests for food/agri by Sysmex Partec using SAFIA tech + flow cytometry |
2024-02-15 |
| Chemspeed–Bruker: investment, 202401– acquisition €na of Chemspeed Technology AG by Bruker |
2024-01-25 |
| Nion–Bruker: investment, 202401 acquisition $23m of Nion by Bruker |
2024-01-03 |
| LumiraDx–Roche: investment, 202312– acquisition $295m + $55m milestones of parts of LumiraDx Group related to innovative PoC technology |
2023-12-29 |
| Elitech–Bruker: investment, 202312– acquisition €870m in cash of Elitech Group from PAI Partners SIGNED Put Option Letter |
2023-12-23 |
| CatSci–Reach Separations: chromatography, 202311– collab strategic allliance offering method development for small molecule development services |
2023-11-28 |
| Oxford Nanopore–Mérieux: investment, 202310 investment £69.1m purchase of 29m ordinary shares at £2.38/share by bioMérieux |
2023-10-19 |
| Olink–Thermo Fisher: investment, 202310– acquisition cash tender offer $3.1b at $26/share by Thermo Fisher |
2023-10-17 |
| MIRO Analytical–Bruker: investment, 202310 majority investment €na by Bruker |
2023-10-04 |
| Refeyn–Alto Marketing: public relations, 202310 service existent by Alto Marketing Ltd |
2023-10-02 |
| CrystalsFirst–Helmholtz: drug discovery technology, 202309–202410 collab developm in joint project LigandML with DESY with funding from IFB Hamburg |
2023-09-01 |
| Abcam–Danaher: investment, 202308– acquisition $24/share in cash = enterprise value $5.7b incl assumed indebtedness + net of acquired cash |
2023-08-28 |
| NuChem Sciences–Sygnature Discovery: investment, acquisition of NuChem Sciences by Sygnature Discovery |
2023-07-31 |
| CrystalsFirst–NexMR: fragment-based drug discovery, 202307– collab combining crystallography technology with NRM for drug discovery |
2023-07-24 |
| Interherence–Bruker: investment, 202307 acquisition $17.3m of Interherence GmbH by Bruker |
2023-07-03 |
| Hema.to–SEVERAL: investment, 202306 seed financing round €3.6m with Elaia Partners + Heal Capital + HTGF |
2023-06-26 |
| Lunaphore–Bio-Techne: investment, 202306–202307 acquisition $170.1m of Lunaphore by Bio-Techne |
2023-06-22 |
| Ellab–Novo Group: investment, 202306– acquisition of Ellab by Novo Holdings from EQT Private Equity + co-shareholders |
2023-06-21 |
| DNTox–SEVERAL: investment, 202306 seed financing round €1.4m led by HTGF |
2023-06-14 |
| Sartorius–Waters: biopharma production technology, 202306– collab expansion integration of PATROL UPLC PAS with Resolute BioSMB platform |
2023-06-05 |
| Midwest Biosolutions–Bionter: analytical instruments, 202305– collab Midwest Bio to promote + sell Bionter products + services in the US |
2023-05-08 |
| Ten23 Health–Bionter: particle counting, 202305– collab developm of methods incl installation of EVE particle counter at Ten23 Heatlh |
2023-05-02 |
| Bio-Techne–Lunaphore: spatial omics, 202304– collab strategic partnership integrating COMET system with RNAscope technology |
2023-04-17 |
| Mérieux–Oxford Nanopore: nanopore technology, 202304– collab strategic exploring nanopore sequencing for infectious disease diagnostics bioMérieux |
2023-04-14 |
| Fasmatech–Bruker: investment, 202303 acquisition $10.3m of Fasmatech by Bruker |
2023-03-03 |
| Astrea Bioseparations–Biotage: investment, 202302– acquisition $190m in shares + $45 cash milestones of Astrea from Gamma Biosciences (KKR) |
2023-02-15 |
| Biotage–KKR: investment, 202302– investment $25m tog with sale of Astrea Bioseparations by Gamma for shares resulting in 17% share in Biotage of Gamma |
2023-02-15 |
| HEL Group–Zyme Communications: public relations, 202302 service existent by Zyme |
2023-02-08 |
| Danaher–Seed Biosciences: cell dispenser, 202302– distribution excl of DinspenCell in US + Asia + resale in Europe by Molecular Devices |
2023-02-07 |
| Agilent–Plasmion: ionisation technology, 202301– collab co-marketing of SICRIT ion source with Agilent Ultivo LC/TQ + LC/MSD iQ MS systems |
2023-01-18 |
| Siemens–ASG Superconductors: magnetic resonance imaging, 202301– collab integration of ASG MRI magnets >7T in Siemens Healthineers UFH MRI systems |
2023-01-18 |
| InDevR–Mérieux: investment, 202301 financing round Series B totalling $9m incl $5m from bioMérieux in connection w partnership |
2023-01-17 |
| Mérieux–InDevR: VaxArray platform, 202301– excl distribution of VaxArray portfolio by bioMérieux in Europe |
2023-01-17 |
| Delta Precision–Astrea Bioseparations: investment, 202301 acquisition of Delta Precision Ltd by Astrea |
2023-01-09 |
| Evosep–Novo Group: investment, 202301 minority investment of $40m by Novo Holdings A/S |
2023-01-09 |
| Acquifer Imaging–Bruker: investment, 202301 acquisition $7.6m of Acquifer Imaging Gmbh + subsidiary Deltabyte GmbH by Bruker |
2023-01-05 |
| Biognosys–Bruker: investment, 202301 acquisition $73.6m of majority share in Biognosys by Bruker |
2023-01-04 |
| Numares–EU (govt): credit, 202212– quasi-equity venture debt financing up to €20m from EIB |
2022-12-20 |
| Numares–SEVERAL: investment, 202212 financing round €20m from existing investors |
2022-12-20 |
| Variolytics–SEVERAL: investment, 202212 seed financing round €7-digit from HTGF + FTTF + business angels |
2022-12-07 |
| Cellesce–Danaher: investment, 202212 acquisition of Cellesce by Molecular Devices |
2022-12-06 |
| Bruker–Leucadia: investor conference, 202211 supply service Bruker presents at Jefferies 2022 London Healthcare Conference |
2022-11-15 |
| Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED |
2022-10-31 |
| MS-Omics–Clinical Microbiomics: investment, 202210 acquisition of MS-Omics ApS by Clinical Microbiomics A/S |
2022-10-17 |
| Cevec–Danaher: investment, 202210 acquisition of Cevec by Cytiva |
2022-10-06 |
| Irubis–EU (govt): investment, 202210 seed financing round totalling €2.8m incl co-investor EIC Fund |
2022-10-06 |
| Irubis–High-Tech Gründerfonds: investment, 202210 seed financing round totalling €2.8m incl co-lead investor HTGF |
2022-10-06 |
| Irubis–OTHER: investment, 202210 seed financing round totalling €2.8m incl business angels as co-investors |
2022-10-06 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
